Black Diamond Therapeutics, Inc.
NASDAQ:BDTX · NASDAQ Global Select
-$0.04 today
Vol 1.91M · Avg 1.31M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-26.87%
Period High
$4.87
Period Low
$1.66
Latest
$1.66
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Abeona Therapeutics Inc.
NASDAQ:ABEO
$325.16M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$294.84M
Fennec Pharmaceuticals Inc.
NASDAQ:FENC
$255.65M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$242.78M
Inventiva S.A.
NASDAQ:IVA
$184.28M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$169.86M
Immuneering Corporation
NASDAQ:IMRX
$161.00M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$160.64M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$117.86M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$86.61M
What is the latest BDTX filing?
The latest filing shown is 8-K dated May 21, 2026.
How many recent filings does BDTX have?
Intrinsic Alpha currently shows 20 recent filings for BDTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.